Obama’s $215 Million Precision Medicine Initiative: Will Congress Fund It and Can It Advance Genetic Testing and the Value of Clinical Laboratory Services?

As proposed, the President’s Precision Medicine Initiative would incorporate a large, volunteer study cohort in innovative ways Even as a new presidential initiative to boost precision medicine makes headlines, there is uncertainty as to how the program can be funded. The Precision Medicine Initiative was announced by President Obama on January 30, 2015. Many pathologists, clinical chemists, and medical laboratory scientists recognize that such a program would pump additional funds into the...

McKinsey & Co. Study Says Health Reform Law May Cause 30% of Employers to Drop Healthcare Benefit Programs

Obamacare reforms scheduled for 2014 may have negative financial impact for pathology groups and clinical laboratories It was not welcome news to many healthcare policymakers when McKinsey & Company released the findings of a survey that indicated that as many as 30% of employers were likely to cease offering health insurance coverage to employees when certain mandates of the Affordable Care Act (ACA) take effect in 2014. Criticism of the McKinsey study was swift, and newspapers and...
;